Tofacitinib Tab (11mg) l

Tofacitinib Tab (11mg)

TACOTINIB 

Tofacitinib (5mg) is a medication primarily used to treat certain autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Here's some key information about Tofacitinib:

1. Mechanism of Action: Tofacitinib belongs to a class of medications known as Janus kinase (JAK) inhibitors. It works by inhibiting the activity of Janus kinases, which are enzymes involved in signaling pathways that regulate the immune system. By blocking these enzymes, Tofacitinib helps reduce inflammation and suppress the immune response that contributes to autoimmune diseases.

2. Indications:

   • Rheumatoid Arthritis: Tofacitinib is approved for the treatment of moderate to severe rheumatoid arthritis in adults who have not responded well to other disease-modifying antirheumatic drugs (DMARDs) such as methotrexate.
   • Psoriatic Arthritis: Tofacitinib is also indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or intolerance to methotrexate or other DMARDs.